Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.

Gynecologic oncology2008Qamar L, Davis R, Anwar A, et al.

Study designOther primary literature

SubjectHuman

Record checks

Study design: Other primary literature
Subject: Human
Publication year: 2008
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Antineoplastic Combined Chemotherapy ProtocolsApoptosisCaffeineCarbazolesCell CycleCell DivisionCell Growth ProcessesCell Line, TumorCisplatinDose-Response Relationship, DrugDrug Resistance, NeoplasmDrug SynergismFemaleG2 PhaseHumansOvarian NeoplasmsProtein Kinase C

DOI 10.1016/j.ygyno.2008.04.039

PMID 18619662

View source →